Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

mipomersen

mipomersen
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Kynamro SOLUTION, SUBCUTANEOUS 200 mg/mL      
Comments:

Kynamro medication guide

Withdrawn from the US market prior to January 2025.

Kynamro is classified as non-formulary, not stocked. It is only available through a specialty pharmacy directly to the patient. The patient may use his/her own supply if needed and initiation should be deferred to the outpatient setting.

 

 

Reviewed: May 28, 2013 (Kynamro)

REMS (Kynamro): View FDA REMS Info

Last updated: Feb. 3, 2025






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2025 Rpharmy, LLC ­ All Rights Reserved